Amyloid-targeting Alzheimer's drugs give us hope – but how will they benefit UK patients?
Amyloid-targeting drugs donanemab and lecanemab show promise for slowing the rate of cognitive decline
Source: telegraph.co.uk
Stay updated with breaking news from However Aziz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amyloid-targeting drugs donanemab and lecanemab show promise for slowing the rate of cognitive decline